Liabilities and Equity of HERON THERAPEUTICS, INC. /DE/ from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
HERON THERAPEUTICS, INC. /DE/ quarterly Liabilities and Equity in USD history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • HERON THERAPEUTICS, INC. /DE/ Liabilities and Equity for the quarter ending 31 Dec 2025 was $255,877,000, a 9.7% increase year-over-year.
Source SEC data
View on sec.gov
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Change (%)

HERON THERAPEUTICS, INC. /DE/ Quarterly Liabilities and Equity (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $255,877,000 +$22,730,000 +9.7% 31 Dec 2025 10-K 26 Feb 2026 2025 FY
Q3 2025 $248,950,000 +$28,173,000 +13% 30 Sep 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 $232,090,000 +$13,954,000 +6.4% 30 Jun 2025 10-Q 08 Aug 2025 2025 Q2
Q1 2025 $235,752,000 +$17,865,000 +8.2% 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q4 2024 $233,147,000 +$10,641,000 +4.8% 31 Dec 2024 10-K 26 Feb 2026 2025 FY
Q3 2024 $220,777,000 -$8,422,000 -3.7% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $218,136,000 +$16,912,000 +8.4% 30 Jun 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 $217,887,000 -$2,991,000 -1.4% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 $222,506,000 -$28,445,000 -11% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q3 2023 $229,199,000 -$42,753,000 -16% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 $201,224,000 -$42,741,000 -18% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 $220,878,000 -$52,845,000 -19% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $250,951,000 -$54,755,000 -18% 31 Dec 2022 10-K 12 Mar 2024 2023 FY
Q3 2022 $271,952,000 -$80,436,000 -23% 30 Sep 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 $243,965,000 -$160,285,000 -40% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 $273,723,000 -$37,209,000 -12% 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 $305,706,000 -$47,850,000 -14% 31 Dec 2021 10-K 29 Mar 2023 2022 FY
Q3 2021 $352,388,000 -$37,635,000 -9.6% 30 Sep 2021 10-Q 03 Nov 2021 2021 Q3
Q2 2021 $404,250,000 -$28,471,000 -6.6% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 $310,932,000 -$168,009,000 -35% 31 Mar 2021 10-Q 10 May 2021 2021 Q1
Q4 2020 $353,556,000 -$159,226,000 -31% 31 Dec 2020 10-K 28 Feb 2022 2021 FY
Q3 2020 $390,023,000 -$2,939,000 -0.75% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 $432,721,000 +$21,055,000 +5.1% 30 Jun 2020 10-Q 05 Aug 2020 2020 Q2
Q1 2020 $478,941,000 +$43,147,000 +9.9% 31 Mar 2020 10-Q 06 May 2020 2020 Q1
Q4 2019 $512,782,000 +$50,603,000 +11% 31 Dec 2019 10-K 24 Feb 2021 2020 FY
Q3 2019 $392,962,000 -$77,934,000 -17% 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 $411,666,000 -$98,890,000 -19% 30 Jun 2019 10-Q 05 Aug 2019 2019 Q2
Q1 2019 $435,794,000 +$252,411,000 +138% 31 Mar 2019 10-Q 09 May 2019 2019 Q1
Q4 2018 $462,179,000 +$227,872,000 +97% 31 Dec 2018 10-K 02 Mar 2020 2019 FY
Q3 2018 $470,896,000 +$352,700,000 +298% 30 Sep 2018 10-Q 07 Nov 2018 2018 Q3
Q2 2018 $510,556,000 +$368,186,000 +259% 30 Jun 2018 10-Q 08 Aug 2018 2018 Q2
Q1 2018 $183,383,000 -$6,175,000 -3.3% 31 Mar 2018 10-Q 10 May 2018 2018 Q1
Q4 2017 $234,307,000 +$166,825,000 +247% 31 Dec 2017 10-K 22 Feb 2019 2018 FY
Q3 2017 $118,196,000 +$19,390,000 +20% 30 Sep 2017 10-Q 06 Nov 2017 2017 Q3
Q2 2017 $142,370,000 +$56,639,000 +66% 30 Jun 2017 10-Q 09 Aug 2017 2017 Q2
Q1 2017 $189,558,000 +$77,712,000 +69% 31 Mar 2017 10-Q 10 May 2017 2017 Q1
Q4 2016 $67,482,000 -$70,363,000 -51% 31 Dec 2016 10-K 27 Feb 2018 2017 FY
Q3 2016 $98,806,000 -$59,345,000 -38% 30 Sep 2016 10-Q 08 Nov 2016 2016 Q3
Q2 2016 $85,731,000 -$90,725,000 -51% 30 Jun 2016 10-Q 08 Aug 2016 2016 Q2
Q1 2016 $111,846,000 +$52,219,000 +88% 31 Mar 2016 10-Q 05 May 2016 2016 Q1
Q4 2015 $137,845,000 +$61,163,000 +80% 31 Dec 2015 10-K 23 Feb 2017 2016 FY
Q3 2015 $158,151,000 +$65,869,000 +71% 30 Sep 2015 10-Q 06 Nov 2015 2015 Q3
Q2 2015 $176,456,000 +$67,818,000 +62% 30 Jun 2015 10-Q 07 Aug 2015 2015 Q2
Q1 2015 $59,627,000 -$3,166,000 -5% 31 Mar 2015 10-Q 08 May 2015 2015 Q1
Q4 2014 $76,682,000 +$745,000 +0.98% 31 Dec 2014 10-K 19 Feb 2016 2015 FY
Q3 2014 $92,282,000 +$65,912,000 +250% 30 Sep 2014 10-Q 06 Nov 2014 2014 Q3
Q2 2014 $108,638,000 +$70,548,000 +185% 30 Jun 2014 10-Q 04 Aug 2014 2014 Q2
Q1 2014 $62,793,000 +$13,814,000 +28% 31 Mar 2014 10-Q 12 May 2014 2014 Q1
Q4 2013 $75,937,000 +$19,965,000 +36% 31 Dec 2013 10-K 13 Mar 2015 2014 FY
Q3 2013 $26,370,000 -$35,391,000 -57% 30 Sep 2013 10-Q 12 Nov 2013 2013 Q3
Q2 2013 $38,090,000 +$23,859,000 +168% 30 Jun 2013 10-Q 08 Aug 2013 2013 Q2
Q1 2013 $48,979,000 +$33,985,000 +227% 31 Mar 2013 10-Q 10 May 2013 2013 Q1
Q4 2012 $55,972,000 +$36,527,000 +188% 31 Dec 2012 10-K 07 Mar 2014 2013 FY
Q3 2012 $61,761,000 +$39,965,000 +183% 30 Sep 2012 10-Q 05 Nov 2012 2012 Q3
Q2 2012 $14,231,000 -$7,890,000 -36% 30 Jun 2012 10-Q 09 Aug 2012 2012 Q2
Q1 2012 $14,994,000 31 Mar 2012 10-Q 10 May 2012 2012 Q1
Q4 2011 $19,445,000 +$16,534,000 +568% 31 Dec 2011 10-K 01 Mar 2013 2012 FY
Q3 2011 $21,796,000 30 Sep 2011 10-Q 07 Nov 2011 2011 Q3
Q2 2011 $22,121,000 30 Jun 2011 10-Q 08 Aug 2011 2011 Q2
Q4 2010 $2,911,000 31 Dec 2010 10-K 26 Mar 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.